Biden administration to retire 'Operation Warp Speed' name January 15, 2021 -- The incoming Biden administration said that it will no longer use the "Operation Warp Speed" term to describe the U.S. government's efforts to combat the COVID-19 pandemic.
Thermo Fisher closes Henogen acquisition January 15, 2021 -- Thermo Fisher Scientific has closed its acquisition of Groupe Novasep's Henogen, a viral vector manufacturing business in Belgium, for approximately 725 million euros ($876 million U.S.) in cash.
Gamma Biosciences to acquire BioMagnetic Solutions January 15, 2021 -- Gamma Biosciences has agreed to acquire BioMagnetic Solutions, a next-generation cell selection and bioseparation technology company.
Fujifilm secures funding, signs lease for new research/manufacturing center January 14, 2021 -- Fujifilm Diosynth Biotechnologies has announced $76 million in financing for the Center for Advanced Biological Innovation and Manufacturing and that a lease for a site in the Boston area has been signed.
Thermo Fisher subsidizes more sequencers for global coronavirus research January 14, 2021 -- Thermo Fisher Scientific is expanding a global SARS-CoV-2 program that provides its next-generation sequencers at subsidized prices to help analyze new strains of the virus and for tracing community transmission.
Cytovia licenses CAR NK tech to NCI January 13, 2021 -- Cytovia Therapeutics has signed a licensing agreement with the National Cancer Institute (NCI), part of the National Institutes of Health, to apply its gene-edited induced pluripotent stem cell-derived technology to develop glypican-3 (GPC3) chimeric antigen receptor (CAR) natural killer (NK) cell therapeutics.